LEVIN JEREMY M
Insider CIK 1256153 · OVID Executive Chairman, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OVID Ovid Therapeutics Inc. | M Exercise deriv | 2026-03-23 | 2026-03-25 | 47,333 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | M Exercise | 2026-03-23 | 2026-03-25 | 47,333 | $1.40 | $66.3K | 3,735,048 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2026-02-26 | 2026-03-02 | 957,000 | — | $0 | 957,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | C Conversion deriv | 2025-12-15 | 2025-12-18 | 71 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | C Conversion | 2025-12-15 | 2025-12-18 | 71,000 | — | $0 | 3,687,715 | SEC↗ |
| OVID Ovid Therapeutics Inc. | P Buy deriv | 2025-12-11 | 2025-12-18 | 35,500 | — | $0 | 35,500 | SEC↗ |
| OVID Ovid Therapeutics Inc. | P Buy deriv | 2025-12-11 | 2025-12-18 | 71 | — | $0 | 71 | SEC↗ |
| OVID Ovid Therapeutics Inc. | P Buy deriv | 2025-12-11 | 2025-12-18 | 47,333 | — | $0 | 47,333 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2025-02-20 | 2025-02-24 | 1,650,000 | — | $0 | 1,650,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | P Buy | 2024-03-18 | 2024-03-20 | 18,248 | $2.76 | $50.4K | 3,616,715 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2024-02-22 | 2024-02-26 | 700,000 | — | $0 | 700,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | G Gift | 2023-12-04 | 2023-12-06 | 573,275 | — | $0 | 4,171,742 | SEC↗ |
| OVID Ovid Therapeutics Inc. | G Gift | 2023-12-04 | 2023-12-06 | 573,275 | — | $0 | 3,598,467 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 600,000 | — | $0 | 600,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2022-04-08 | 2022-04-12 | 423,244 | — | $0 | 423,244 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2022-02-03 | 2022-02-04 | 600,000 | — | $0 | 600,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2020-12-17 | 2020-12-21 | 650,000 | — | $0 | 650,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | P Buy | 2020-08-28 | 2020-09-01 | 8,488 | $5.84 | $49.6K | 5,792,530 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 600,000 | — | $0 | 600,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | P Buy | 2019-10-08 | 2019-10-10 | 60,000 | $2.50 | $150.0K | 4,736,529 | SEC↗ |
| OVID Ovid Therapeutics Inc. | G Gift | 2019-09-20 | 2024-02-14 | 465,116 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-02-24 | 2019-02-26 | 250,000 | — | $0 | 250,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | P Buy | 2019-02-22 | 2019-02-26 | 75,000 | $2.00 | $150.0K | 4,676,529 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2018-01-19 | 2018-01-23 | 290,000 | — | $0 | 290,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | P Buy | 2017-08-25 | 2017-08-28 | 15,334 | $7.15 | $109.6K | 4,601,529 | SEC↗ |
| OVID Ovid Therapeutics Inc. | C Conversion deriv | 2017-05-10 | 2017-05-10 | 400,150 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | C Conversion deriv | 2017-05-10 | 2017-05-10 | 35,461 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | C Conversion | 2017-05-10 | 2017-05-10 | 35,461 | — | $0 | 35,461 | SEC↗ |
| OVID Ovid Therapeutics Inc. | C Conversion | 2017-05-10 | 2017-05-10 | 400,150 | — | $0 | 4,586,195 | SEC↗ |